CAR-transduced NK cell therapy

CAR-transduced NK cell therapy

Enabling clinical grade manufacturing of gene-engineered NK cells [WEBINAR]Подробнее

Enabling clinical grade manufacturing of gene-engineered NK cells [WEBINAR]

How cell and gene therapies can transform the treatment of solid tumoursПодробнее

How cell and gene therapies can transform the treatment of solid tumours

The Promise of CAR NK Cell TherapyПодробнее

The Promise of CAR NK Cell Therapy

From CAR NK cell research to clinical NK cell engineering [WEBINAR]Подробнее

From CAR NK cell research to clinical NK cell engineering [WEBINAR]

Get ready for CAR NK cell manufacturingПодробнее

Get ready for CAR NK cell manufacturing

Advances in off-the-shelf CAR T-cellsПодробнее

Advances in off-the-shelf CAR T-cells

What’s new in the initial management of Hodgkin lymphoma?Подробнее

What’s new in the initial management of Hodgkin lymphoma?

Automated manufacturing of CAR NK cells [WEBINAR]Подробнее

Automated manufacturing of CAR NK cells [WEBINAR]

Targetting cancer with allogeneic NK cell therapiesПодробнее

Targetting cancer with allogeneic NK cell therapies

Michael Jain, MD, regarding CAR-natural killer (NK) cell therapyПодробнее

Michael Jain, MD, regarding CAR-natural killer (NK) cell therapy

NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma CellsПодробнее

NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma Cells

Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutionsПодробнее

Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutions